human t lymphocyte cells Search Results


primary human t lymphocytes  (Celprogen Inc)
91
Celprogen Inc primary human t lymphocytes
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Primary Human T Lymphocytes, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human t lymphocytes/product/Celprogen Inc
Average 91 stars, based on 1 article reviews
primary human t lymphocytes - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
human lymphocytic cells  (CEM Corporation)
90
CEM Corporation human lymphocytic cells
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human Lymphocytic Cells, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lymphocytic cells/product/CEM Corporation
Average 90 stars, based on 1 article reviews
human lymphocytic cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t-lymphocyte cells  (CEM Corporation)
90
CEM Corporation human t-lymphocyte cells
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Lymphocyte Cells, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t-lymphocyte cells/product/CEM Corporation
Average 90 stars, based on 1 article reviews
human t-lymphocyte cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t-cell acute lymphocytic leukaemia  (CEM Corporation)
90
CEM Corporation human t-cell acute lymphocytic leukaemia
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Cell Acute Lymphocytic Leukaemia, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t-cell acute lymphocytic leukaemia/product/CEM Corporation
Average 90 stars, based on 1 article reviews
human t-cell acute lymphocytic leukaemia - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
jurkat (human t lymphocyte) cells  (Servicebio Inc)
90
Servicebio Inc jurkat (human t lymphocyte) cells
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Jurkat (Human T Lymphocyte) Cells, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jurkat (human t lymphocyte) cells/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
jurkat (human t lymphocyte) cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t lymphocyte cell line jurkat  (AddexBio Inc)
90
AddexBio Inc human t lymphocyte cell line jurkat
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Lymphocyte Cell Line Jurkat, supplied by AddexBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t lymphocyte cell line jurkat/product/AddexBio Inc
Average 90 stars, based on 1 article reviews
human t lymphocyte cell line jurkat - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t lymphocyte cell surface molecules defined by the workshop monoclonal antibodies (t cell protocol)  (Verlag GmbH)
90
Verlag GmbH human t lymphocyte cell surface molecules defined by the workshop monoclonal antibodies (t cell protocol)
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Lymphocyte Cell Surface Molecules Defined By The Workshop Monoclonal Antibodies (T Cell Protocol), supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t lymphocyte cell surface molecules defined by the workshop monoclonal antibodies (t cell protocol)/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
human t lymphocyte cell surface molecules defined by the workshop monoclonal antibodies (t cell protocol) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
infiltration of helper/inducer t lymphocytes heralds central nervous system damage in human t-cell leukemia virus infection  (Akizuki Denshi Tsusho Co Ltd)
90
Akizuki Denshi Tsusho Co Ltd infiltration of helper/inducer t lymphocytes heralds central nervous system damage in human t-cell leukemia virus infection
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Infiltration Of Helper/Inducer T Lymphocytes Heralds Central Nervous System Damage In Human T Cell Leukemia Virus Infection, supplied by Akizuki Denshi Tsusho Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/infiltration of helper/inducer t lymphocytes heralds central nervous system damage in human t-cell leukemia virus infection/product/Akizuki Denshi Tsusho Co Ltd
Average 90 stars, based on 1 article reviews
infiltration of helper/inducer t lymphocytes heralds central nervous system damage in human t-cell leukemia virus infection - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t-lymphocytic cell line  (Blackwell Science Ltd)
90
Blackwell Science Ltd human t-lymphocytic cell line
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Lymphocytic Cell Line, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t-lymphocytic cell line/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
human t-lymphocytic cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
t cells (human t lymphocytes)  (Keygen Biotech)
90
Keygen Biotech t cells (human t lymphocytes)
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
T Cells (Human T Lymphocytes), supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t cells (human t lymphocytes)/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
t cells (human t lymphocytes) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
monoclonal antibodies specific for different cell-free products of activated human t lymphocytes  (Centocor Inc)
90
Centocor Inc monoclonal antibodies specific for different cell-free products of activated human t lymphocytes
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Monoclonal Antibodies Specific For Different Cell Free Products Of Activated Human T Lymphocytes, supplied by Centocor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibodies specific for different cell-free products of activated human t lymphocytes/product/Centocor Inc
Average 90 stars, based on 1 article reviews
monoclonal antibodies specific for different cell-free products of activated human t lymphocytes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t-lymphocyte, acute t cell leukemia (jurkat e6.1)  (National Centre for Cell Science)
90
National Centre for Cell Science human t-lymphocyte, acute t cell leukemia (jurkat e6.1)
Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary <t>human</t> <t>T</t> lymphocyte-derived serum-free CM, respectively.
Human T Lymphocyte, Acute T Cell Leukemia (Jurkat E6.1), supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t-lymphocyte, acute t cell leukemia (jurkat e6.1)/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human t-lymphocyte, acute t cell leukemia (jurkat e6.1) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary human T lymphocyte-derived serum-free CM, respectively.

Journal: Genes & Diseases

Article Title: Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

doi: 10.1016/j.gendis.2022.08.007

Figure Lengend Snippet: Suppression of tumorigenic behaviors of U2OS and MG63 OS cells by D-cAMP/cAMP- treated Jurkat cell-derived CM. CN = control, D-cAMP = Dibutyryl cAMP, CW = CW008, and CM = conditioned medium. The double asterisk indicates P < 0.01. (A, B) Suppression of MTT-based viability of U2OS and MG63 OS cells by D-cAMP-treated Jurkat cell-derived CM, respectively. (C – E) Suppression of MTT-based viability, EdU-based proliferation, and transwell invasion of U2OS cells by cAMP-treated Jurkat cell-derived CM. (F, G) Suppression of MTT-based viability of U2OS and MG63 OS cells by CW008-treated primary human T lymphocyte-derived serum-free CM, respectively.

Article Snippet: Primary human T lymphocytes (#33002-02, Celprogen, CA, USA) were cultured in CTS™ OpTmizer™ T-Cell Expansion SFM (#A3705001, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Derivative Assay